What is Assembly Biosciences's D&A?

Assembly Biosciences (ASMB) reported D&A of $26K in Q1 2026.

How has Assembly Biosciences's D&A changed year-over-year?

Assembly Biosciences's D&A decreased by 21.2% year-over-year, from $33K to $26K.

What is the long-term trend for Assembly Biosciences's D&A?

Over 4 years (2021 to 2025), Assembly Biosciences's D&A has grown at a -27.5% compound annual growth rate (CAGR), from $466K to $129K.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Assembly Biosciences ASMB D&A

D&A at other companies

Arrowhead ResearchARWR

$6.37M+4.7%

ALN

Alnylam PharmaceuticalsALNY

$13.55M-5.9%

Avalo TherapeuticsAVTX

$17K-87.4%

Arbutus Biopharma CorporationABUS

$11K-96.7%

Vir Biotechnology, Inc.VIR

$2.81M-2.0%

Maravai LifeSciences Holdings, Inc.MRVI

$4.9M-13.9%

Other financials

Income statement

See full

Revenue$8.2M-12.8%

Operating income-$11.4M-14.4%

Net income-$9.1M-3.0%

EPS (diluted)-$0.54+53.8%

Balance sheet

See full

Cash & equivalents$31.1M+32.9%

Total debt$2.5M-17.5%

Total equity$198.6M+632%

Total assets$235.5M+138%

Cash flow

See full

Operating cash flow-$22.1M+5.7%

CapEx$19.0K—

Free cash flow-$22.1M+5.6%

Valuation

See full

Market cap$480.77M+262%

Enterprise value$452.14M+302%

P/S6.8×+2.6×

Profitability

See full

Operating margin-116.8%-26.1pp

Net margin-103.6%-22.7pp

FCF margin-150%-231pp

Returns & leverage

See full

Return on equity-36.9%-15.1pp

Debt / equity0×-0.1×

Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Assembly Biosciences's D&A?: Assembly Biosciences (ASMB) reported D&A of $26K in Q1 2026.
How has Assembly Biosciences's D&A changed year-over-year?: Assembly Biosciences's D&A decreased by 21.2% year-over-year, from $33K to $26K.
What is the long-term trend for Assembly Biosciences's D&A?: Over 4 years (2021 to 2025), Assembly Biosciences's D&A has grown at a -27.5% compound annual growth rate (CAGR), from $466K to $129K.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.